Century Therapeutics Inc (NASDAQ:IPSC) price on Thursday, July 03, rose 0.02% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.56.
A look at the stock’s price movement, the close in the last trading session was $0.56, moving within a range at $0.5501 and $0.5643. The beta value (5-Year monthly) was 1.775. Turning to its 52-week performance, $3.29 and $0.34 were the 52-week high and 52-week low respectively. Overall, IPSC moved -2.63% over the past month.
Century Therapeutics Inc’s market cap currently stands at around $47.83 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-15.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IPSC is a Hold. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 3 recommend IPSC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
IPSC’s current price about -4.28% and -0.39% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.49, while 7-day volatility ratio is 5.37% and 6.30% in the 30-day chart. Further, Century Therapeutics Inc (IPSC) has a beta value of 1.78. Analysts have given the company’s stock an average 52-week price target of $14, forecast between a low of $5 and high of $27. Looking at the price targets, the low is -792.86% off current price level while to achieve the yearly target high, price needs to move -4721.43%. Nonetheless, investors will most likely welcome a -2400.0% jump to $14 which is the analysts’ median price.
If we refocus on Century Therapeutics Inc (NASDAQ:IPSC), historical trading data shows that trading volumes averaged 1.21 over the past 10 days and 857.54K over the past 3 months. The company’s latest data on shares outstanding shows there are 86.15 million shares.
The 52.88% of Century Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 28.81% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.32 million on 2025-06-13, giving us a short ratio of 2.54. The data shows that as of 2025-06-13 short interest in Century Therapeutics Inc (IPSC) stood at 401.0 of shares outstanding, with shares short falling to 2.56 million registered in 2025-05-15. Current price change has pushed the stock -76.97% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IPSC stock continues to rise going into the next quarter.
